Rank | Gene Set | Z-score |
---|---|---|
1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.16384237 |
2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.57612477 |
3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.57612477 |
4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.36013177 |
5 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.17121349 |
6 | negative regulation of cell killing (GO:0031342) | 5.17121349 |
7 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.90250068 |
8 | regulation of gamma-delta T cell activation (GO:0046643) | 4.65721065 |
9 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.62061974 |
10 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.52682384 |
11 | positive regulation of B cell differentiation (GO:0045579) | 4.47910694 |
12 | detection of other organism (GO:0098543) | 4.28592656 |
13 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.24156125 |
14 | leukocyte aggregation (GO:0070486) | 4.19147946 |
15 | microglial cell activation (GO:0001774) | 4.17732640 |
16 | negative regulation of T cell mediated immunity (GO:0002710) | 4.17182196 |
17 | positive thymic T cell selection (GO:0045059) | 4.14687604 |
18 | negative T cell selection (GO:0043383) | 4.12732373 |
19 | negative thymic T cell selection (GO:0045060) | 4.10997261 |
20 | regulation of B cell differentiation (GO:0045577) | 4.09202178 |
21 | detection of molecule of bacterial origin (GO:0032490) | 4.08796615 |
22 | modulation by symbiont of host defense response (GO:0052031) | 4.07957858 |
23 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.07957858 |
24 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.07957858 |
25 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.07957858 |
26 | modulation by symbiont of host immune response (GO:0052553) | 4.07957858 |
27 | positive regulation by symbiont of host defense response (GO:0052509) | 4.07957858 |
28 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.04650332 |
29 | detection of bacterium (GO:0016045) | 3.99700461 |
30 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.92623973 |
31 | tolerance induction (GO:0002507) | 3.87053523 |
32 | B cell receptor signaling pathway (GO:0050853) | 3.86922499 |
33 | detection of external biotic stimulus (GO:0098581) | 3.86794291 |
34 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.72487122 |
35 | positive regulation of granulocyte differentiation (GO:0030854) | 3.61063663 |
36 | cellular extravasation (GO:0045123) | 3.57755537 |
37 | thymic T cell selection (GO:0045061) | 3.56176096 |
38 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.54665734 |
39 | T cell migration (GO:0072678) | 3.53534444 |
40 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.52050125 |
41 | neutrophil activation involved in immune response (GO:0002283) | 3.51431008 |
42 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.51274272 |
43 | macrophage activation (GO:0042116) | 3.49749596 |
44 | T cell selection (GO:0045058) | 3.44801828 |
45 | positive T cell selection (GO:0043368) | 3.44285754 |
46 | response to interleukin-15 (GO:0070672) | 3.42870893 |
47 | detection of biotic stimulus (GO:0009595) | 3.41229333 |
48 | neutrophil activation (GO:0042119) | 3.39317814 |
49 | response to muramyl dipeptide (GO:0032495) | 3.38596601 |
50 | NIK/NF-kappaB signaling (GO:0038061) | 3.37911269 |
51 | interferon-gamma production (GO:0032609) | 3.31731576 |
52 | macrophage activation involved in immune response (GO:0002281) | 3.28426023 |
53 | negative regulation of phagocytosis (GO:0050765) | 3.27381348 |
54 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.24995054 |
55 | immunoglobulin mediated immune response (GO:0016064) | 3.24684266 |
56 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.22310809 |
57 | regulation of tolerance induction (GO:0002643) | 3.18223617 |
58 | granulocyte activation (GO:0036230) | 3.17477460 |
59 | positive regulation of interferon-alpha production (GO:0032727) | 3.16599700 |
60 | positive regulation of mast cell activation (GO:0033005) | 3.16264145 |
61 | negative regulation of granulocyte differentiation (GO:0030853) | 3.14419538 |
62 | respiratory burst (GO:0045730) | 3.14004315 |
63 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.13894814 |
64 | defense response to protozoan (GO:0042832) | 3.13346777 |
65 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.13136414 |
66 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.12743836 |
67 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.12425579 |
68 | regulation of mast cell degranulation (GO:0043304) | 3.10073603 |
69 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.09027010 |
70 | leukocyte cell-cell adhesion (GO:0007159) | 3.07207371 |
71 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.06629442 |
72 | myeloid leukocyte mediated immunity (GO:0002444) | 3.05914647 |
73 | myeloid dendritic cell activation (GO:0001773) | 3.04425789 |
74 | regulation of interferon-alpha production (GO:0032647) | 3.03837010 |
75 | positive regulation of antigen processing and presentation (GO:0002579) | 3.03688624 |
76 | leukocyte degranulation (GO:0043299) | 3.00570526 |
77 | mature B cell differentiation (GO:0002335) | 3.00476974 |
78 | response to peptidoglycan (GO:0032494) | 2.99589542 |
79 | regulation of T cell tolerance induction (GO:0002664) | 2.97543303 |
80 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.97259180 |
81 | negative regulation of adaptive immune response (GO:0002820) | 2.96815682 |
82 | regulation of mast cell activation (GO:0033003) | 2.96384877 |
83 | B cell mediated immunity (GO:0019724) | 2.96244579 |
84 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.94057137 |
85 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.93316336 |
86 | B cell homeostasis (GO:0001782) | 2.92734058 |
87 | regulation of regulatory T cell differentiation (GO:0045589) | 2.91674834 |
88 | myeloid cell activation involved in immune response (GO:0002275) | 2.90714765 |
89 | negative regulation of interleukin-12 production (GO:0032695) | 2.90638540 |
90 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.90605315 |
91 | cellular response to interleukin-15 (GO:0071350) | 2.90084994 |
92 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.89696293 |
93 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.87675727 |
94 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.87589043 |
95 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.87589043 |
96 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.87483713 |
97 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.86766018 |
98 | lymphocyte homeostasis (GO:0002260) | 2.84966816 |
99 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.83486492 |
100 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.83256594 |
101 | myeloid dendritic cell differentiation (GO:0043011) | 2.82015345 |
102 | T cell homeostasis (GO:0043029) | 2.81331247 |
103 | germinal center formation (GO:0002467) | 2.79411291 |
104 | pinocytosis (GO:0006907) | 2.77760810 |
105 | T cell costimulation (GO:0031295) | 2.76201299 |
106 | positive regulation of interleukin-2 production (GO:0032743) | 2.74510146 |
107 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.72040461 |
108 | response to host immune response (GO:0052572) | 2.72040461 |
109 | lymphocyte costimulation (GO:0031294) | 2.70308146 |
110 | hepatocyte apoptotic process (GO:0097284) | 2.70130372 |
111 | T cell receptor signaling pathway (GO:0050852) | 2.68496771 |
112 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.65836896 |
113 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.65637854 |
114 | positive regulation of histone deacetylation (GO:0031065) | 2.65069612 |
115 | response to type I interferon (GO:0034340) | 2.64323959 |
116 | mast cell activation (GO:0045576) | 2.63799602 |
117 | neutrophil mediated immunity (GO:0002446) | 2.63776116 |
118 | natural killer cell differentiation (GO:0001779) | 2.63464667 |
119 | response to fungus (GO:0009620) | 2.62225209 |
120 | cellular response to zinc ion (GO:0071294) | 2.62214977 |
121 | activated T cell proliferation (GO:0050798) | 2.61691041 |
122 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.61167314 |
123 | response to host (GO:0075136) | 2.60361538 |
124 | response to host defenses (GO:0052200) | 2.60361538 |
125 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.60361538 |
126 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.59274099 |
127 | positive regulation of isotype switching (GO:0045830) | 2.58754801 |
128 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.58136431 |
129 | response to protozoan (GO:0001562) | 2.58017792 |
130 | regulation of response to interferon-gamma (GO:0060330) | 2.57845400 |
131 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.57227394 |
132 | cellular response to type I interferon (GO:0071357) | 2.56805160 |
133 | type I interferon signaling pathway (GO:0060337) | 2.56805160 |
134 | mannose metabolic process (GO:0006013) | 2.56261506 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.84827749 |
2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.67196785 |
3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.30563993 |
4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.83896988 |
5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.49868323 |
6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.49524109 |
7 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.41391690 |
8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.23161363 |
9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.20946791 |
10 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.15585732 |
11 | MYC_22102868_ChIP-Seq_BL_Human | 3.04051690 |
12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.99607862 |
13 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.90789155 |
14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.88119653 |
15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.84972614 |
16 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.81044269 |
17 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.77465645 |
18 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.76040573 |
19 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.72481354 |
20 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.64051052 |
21 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.61931223 |
22 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.53440823 |
23 | MYB_26560356_Chip-Seq_TH2_Human | 2.51960519 |
24 | MAF_26560356_Chip-Seq_TH1_Human | 2.40754494 |
25 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.35244568 |
26 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.33394343 |
27 | MYB_26560356_Chip-Seq_TH1_Human | 2.26109045 |
28 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.19072230 |
29 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.15082949 |
30 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.13861752 |
31 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.12691260 |
32 | UTX_26944678_Chip-Seq_JUKART_Human | 2.10476886 |
33 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.10302810 |
34 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.09071236 |
35 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.02807463 |
36 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.01167658 |
37 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.93993887 |
38 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.93722265 |
39 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.92305445 |
40 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.83982660 |
41 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.80400862 |
42 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.76561393 |
43 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.70988065 |
44 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.70962243 |
45 | GATA1_22025678_ChIP-Seq_K562_Human | 1.65800770 |
46 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.64151280 |
47 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.58744475 |
48 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.57262779 |
49 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.56679090 |
50 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.53334612 |
51 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.51870762 |
52 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51124293 |
53 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.50123653 |
54 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.48981174 |
55 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.47840663 |
56 | MAF_26560356_Chip-Seq_TH2_Human | 1.47185520 |
57 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.42365604 |
58 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.41902725 |
59 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39217837 |
60 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.38286903 |
61 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.36383154 |
62 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.33929690 |
63 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.29252624 |
64 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.26481964 |
65 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.26256366 |
66 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.26090102 |
67 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25728210 |
68 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.24961604 |
69 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.21514477 |
70 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.20093816 |
71 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.19952927 |
72 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.17770757 |
73 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15634254 |
74 | GATA3_26560356_Chip-Seq_TH2_Human | 1.13843650 |
75 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.13414326 |
76 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.13340250 |
77 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12835114 |
78 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.06128187 |
79 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.03824924 |
80 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.02721689 |
81 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.01270297 |
82 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01124817 |
83 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.99228108 |
84 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.96397827 |
85 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.95655638 |
86 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.94049831 |
87 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.93738934 |
88 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.92965705 |
89 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.92138319 |
90 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92054167 |
91 | GATA1_19941826_ChIP-Seq_K562_Human | 0.91845985 |
92 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90597126 |
93 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89421797 |
94 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.89268310 |
95 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.88863965 |
96 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.87854339 |
97 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.86406205 |
98 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.85075919 |
99 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85004839 |
100 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84324743 |
101 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.83380959 |
102 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.82016679 |
103 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81717980 |
104 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.79412875 |
105 | * GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.78969146 |
106 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.78951988 |
107 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76626083 |
108 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.75362429 |
109 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.74688879 |
110 | GATA3_26560356_Chip-Seq_TH1_Human | 0.74088614 |
111 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.70325877 |
112 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.67217628 |
113 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.65945611 |
114 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.63625490 |
115 | * SPI1_20517297_ChIP-Seq_HL60_Human | 0.63562876 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 3.79140821 |
2 | MP0003303_peritoneal_inflammation | 3.04047431 |
3 | MP0003436_decreased_susceptibility_to | 3.03130460 |
4 | MP0000685_abnormal_immune_system | 3.01800600 |
5 | * MP0001800_abnormal_humoral_immune | 2.94185721 |
6 | MP0001790_abnormal_immune_system | 2.92913977 |
7 | MP0005387_immune_system_phenotype | 2.92913977 |
8 | MP0005671_abnormal_response_to | 2.86987253 |
9 | MP0005000_abnormal_immune_tolerance | 2.62252690 |
10 | MP0002452_abnormal_antigen_presenting | 2.62149440 |
11 | MP0002419_abnormal_innate_immunity | 2.53012875 |
12 | MP0003300_gastrointestinal_ulcer | 2.52724209 |
13 | MP0002723_abnormal_immune_serum | 2.49932834 |
14 | MP0003763_abnormal_thymus_physiology | 2.46002756 |
15 | MP0002166_altered_tumor_susceptibility | 2.45719314 |
16 | MP0002420_abnormal_adaptive_immunity | 2.42134929 |
17 | MP0001819_abnormal_immune_cell | 2.40539716 |
18 | MP0005025_abnormal_response_to | 2.38879981 |
19 | MP0009785_altered_susceptibility_to | 2.38100869 |
20 | MP0002396_abnormal_hematopoietic_system | 2.34420501 |
21 | MP0005464_abnormal_platelet_physiology | 2.30950661 |
22 | MP0002398_abnormal_bone_marrow | 2.20641876 |
23 | MP0006082_CNS_inflammation | 2.11047448 |
24 | MP0002148_abnormal_hypersensitivity_rea | 2.06173384 |
25 | * MP0000716_abnormal_immune_system | 2.03416629 |
26 | MP0001873_stomach_inflammation | 2.02945360 |
27 | MP0002405_respiratory_system_inflammati | 2.00879088 |
28 | MP0008260_abnormal_autophagy | 1.94383365 |
29 | MP0004947_skin_inflammation | 1.91940977 |
30 | * MP0000689_abnormal_spleen_morphology | 1.89461584 |
31 | MP0000569_abnormal_digit_pigmentation | 1.86565141 |
32 | MP0004510_myositis | 1.86123674 |
33 | MP0009278_abnormal_bone_marrow | 1.85090587 |
34 | MP0002006_tumorigenesis | 1.84602744 |
35 | MP0004381_abnormal_hair_follicle | 1.84388609 |
36 | MP0005058_abnormal_lysosome_morphology | 1.83956970 |
37 | MP0002722_abnormal_immune_system | 1.82779464 |
38 | MP0010155_abnormal_intestine_physiology | 1.80387167 |
39 | MP0001845_abnormal_inflammatory_respons | 1.74833688 |
40 | MP0001853_heart_inflammation | 1.74739592 |
41 | MP0003191_abnormal_cellular_cholesterol | 1.71915299 |
42 | MP0004808_abnormal_hematopoietic_stem | 1.70913584 |
43 | * MP0002429_abnormal_blood_cell | 1.69572307 |
44 | MP0005451_abnormal_body_composition | 1.63431037 |
45 | MP0003724_increased_susceptibility_to | 1.63139325 |
46 | MP0001545_abnormal_hematopoietic_system | 1.60956733 |
47 | MP0005397_hematopoietic_system_phenotyp | 1.60956733 |
48 | MP0003172_abnormal_lysosome_physiology | 1.60506370 |
49 | MP0009333_abnormal_splenocyte_physiolog | 1.58465512 |
50 | MP0002138_abnormal_hepatobiliary_system | 1.58163662 |
51 | MP0000703_abnormal_thymus_morphology | 1.57585112 |
52 | MP0000465_gastrointestinal_hemorrhage | 1.56354260 |
53 | MP0009840_abnormal_foam_cell | 1.54639671 |
54 | MP0003183_abnormal_peptide_metabolism | 1.54483387 |
55 | MP0001533_abnormal_skeleton_physiology | 1.47391420 |
56 | MP0005174_abnormal_tail_pigmentation | 1.46040458 |
57 | MP0008469_abnormal_protein_level | 1.44466004 |
58 | MP0004883_abnormal_blood_vessel | 1.41723141 |
59 | MP0005310_abnormal_salivary_gland | 1.34000055 |
60 | MP0002933_joint_inflammation | 1.33582095 |
61 | MP0003866_abnormal_defecation | 1.26823984 |
62 | MP0002132_abnormal_respiratory_system | 1.21663824 |
63 | MP0005360_urolithiasis | 1.21276213 |
64 | MP0001851_eye_inflammation | 1.15723799 |
65 | MP0000858_altered_metastatic_potential | 1.11632995 |
66 | MP0003448_altered_tumor_morphology | 1.10753939 |
67 | MP0005076_abnormal_cell_differentiation | 1.09640913 |
68 | MP0008057_abnormal_DNA_replication | 1.07054165 |
69 | MP0010307_abnormal_tumor_latency | 1.06750390 |
70 | MP0010352_gastrointestinal_tract_polyps | 1.05600100 |
71 | MP0000609_abnormal_liver_physiology | 1.01915370 |
72 | MP0003690_abnormal_glial_cell | 1.01683867 |
73 | MP0009764_decreased_sensitivity_to | 1.01301090 |
74 | MP0000490_abnormal_crypts_of | 1.00296039 |
75 | MP0003566_abnormal_cell_adhesion | 0.99550255 |
76 | MP0002998_abnormal_bone_remodeling | 0.95106186 |
77 | MP0005164_abnormal_response_to | 0.93914021 |
78 | MP0009763_increased_sensitivity_to | 0.92491958 |
79 | MP0002277_abnormal_respiratory_mucosa | 0.87558435 |
80 | MP0002254_reproductive_system_inflammat | 0.87128919 |
81 | MP0003252_abnormal_bile_duct | 0.82609774 |
82 | MP0002019_abnormal_tumor_incidence | 0.81958623 |
83 | MP0002928_abnormal_bile_duct | 0.81195601 |
84 | MP0000343_altered_response_to | 0.81030642 |
85 | MP0005365_abnormal_bile_salt | 0.80163231 |
86 | MP0000604_amyloidosis | 0.79827517 |
87 | MP0004130_abnormal_muscle_cell | 0.79508839 |
88 | MP0000015_abnormal_ear_pigmentation | 0.79136710 |
89 | MP0005023_abnormal_wound_healing | 0.78804135 |
90 | MP0001986_abnormal_taste_sensitivity | 0.78749374 |
91 | MP0005075_abnormal_melanosome_morpholog | 0.78641426 |
92 | MP0003656_abnormal_erythrocyte_physiolo | 0.77109533 |
93 | MP0002139_abnormal_hepatobiliary_system | 0.76656022 |
94 | MP0002136_abnormal_kidney_physiology | 0.75681715 |
95 | MP0000249_abnormal_blood_vessel | 0.73162125 |
96 | MP0003453_abnormal_keratinocyte_physiol | 0.72671554 |
97 | MP0008961_abnormal_basal_metabolism | 0.72225779 |
98 | MP0003787_abnormal_imprinting | 0.70557618 |
99 | MP0000598_abnormal_liver_morphology | 0.69510791 |
100 | MP0003221_abnormal_cardiomyocyte_apopto | 0.69273071 |
101 | MP0001663_abnormal_digestive_system | 0.69191570 |
102 | MP0010329_abnormal_lipoprotein_level | 0.68700638 |
103 | MP0000371_diluted_coat_color | 0.67597306 |
104 | MP0002009_preneoplasia | 0.66100344 |
105 | MP0003075_altered_response_to | 0.66086613 |
106 | MP0005166_decreased_susceptibility_to | 0.65435195 |
107 | MP0008004_abnormal_stomach_pH | 0.65269308 |
108 | MP0003828_pulmonary_edema | 0.61030289 |
109 | MP0003091_abnormal_cell_migration | 0.60776249 |
110 | MP0002877_abnormal_melanocyte_morpholog | 0.59944931 |
111 | MP0009765_abnormal_xenobiotic_induced | 0.59692342 |
112 | MP0003795_abnormal_bone_structure | 0.58061054 |
113 | MP0003045_fibrosis | 0.57667883 |
114 | MP0005390_skeleton_phenotype | 0.55147193 |
115 | MP0004484_altered_response_of | 0.54802519 |
116 | MP0009643_abnormal_urine_homeostasis | 0.54541875 |
117 | MP0009115_abnormal_fat_cell | 0.54087490 |
118 | MP0002332_abnormal_exercise_endurance | 0.53178820 |
119 | MP0008874_decreased_physiological_sensi | 0.52123002 |
120 | MP0005376_homeostasis/metabolism_phenot | 0.46082541 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent abscess formation (HP:0002722) | 5.22552189 |
2 | Eczematoid dermatitis (HP:0000976) | 5.13748954 |
3 | Recurrent bacterial skin infections (HP:0005406) | 4.98690112 |
4 | * Recurrent fungal infections (HP:0002841) | 4.12312650 |
5 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.10058496 |
6 | * Recurrent viral infections (HP:0004429) | 4.01135328 |
7 | IgM deficiency (HP:0002850) | 3.87774813 |
8 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.72100988 |
9 | Recurrent skin infections (HP:0001581) | 3.69131662 |
10 | Colitis (HP:0002583) | 3.56039793 |
11 | T lymphocytopenia (HP:0005403) | 3.55649000 |
12 | Myositis (HP:0100614) | 3.54910762 |
13 | Inflammation of the large intestine (HP:0002037) | 3.50589073 |
14 | Panhypogammaglobulinemia (HP:0003139) | 3.49797511 |
15 | Chronic otitis media (HP:0000389) | 3.49619906 |
16 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.49132099 |
17 | Abnormality of T cell number (HP:0011839) | 3.48377339 |
18 | Recurrent cutaneous fungal infections (HP:0011370) | 3.43857036 |
19 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.43857036 |
20 | Meningitis (HP:0001287) | 3.41014563 |
21 | Cellulitis (HP:0100658) | 3.38658829 |
22 | Gastrointestinal inflammation (HP:0004386) | 3.36517079 |
23 | Autoimmune thrombocytopenia (HP:0001973) | 3.36293742 |
24 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.35085150 |
25 | Mediastinal lymphadenopathy (HP:0100721) | 3.30646685 |
26 | Abnormality of the fingertips (HP:0001211) | 3.25100549 |
27 | Keratoconjunctivitis (HP:0001096) | 3.18067304 |
28 | Abnormality of macrophages (HP:0004311) | 3.16171163 |
29 | Systemic lupus erythematosus (HP:0002725) | 3.11441691 |
30 | Recurrent bronchitis (HP:0002837) | 3.10939721 |
31 | Agammaglobulinemia (HP:0004432) | 3.09354222 |
32 | Spontaneous hematomas (HP:0007420) | 3.09299613 |
33 | Thyroiditis (HP:0100646) | 3.05339442 |
34 | Abnormality of T cells (HP:0002843) | 3.02131420 |
35 | Pustule (HP:0200039) | 3.01499797 |
36 | Chronic obstructive pulmonary disease (HP:0006510) | 2.98420133 |
37 | Obstructive lung disease (HP:0006536) | 2.98420133 |
38 | Periodontitis (HP:0000704) | 2.97399561 |
39 | Nasal polyposis (HP:0100582) | 2.96713092 |
40 | Abnormality of B cell number (HP:0010975) | 2.89050421 |
41 | B lymphocytopenia (HP:0010976) | 2.89050421 |
42 | Gingival bleeding (HP:0000225) | 2.85682759 |
43 | Prolonged bleeding time (HP:0003010) | 2.84199907 |
44 | Gingivitis (HP:0000230) | 2.83588148 |
45 | Increased IgE level (HP:0003212) | 2.76094295 |
46 | Autoimmune hemolytic anemia (HP:0001890) | 2.74111540 |
47 | Stomatitis (HP:0010280) | 2.72889316 |
48 | Orchitis (HP:0100796) | 2.72225681 |
49 | * Vasculitis (HP:0002633) | 2.70625346 |
50 | Myocardial infarction (HP:0001658) | 2.69472148 |
51 | Epistaxis (HP:0000421) | 2.67215198 |
52 | Impaired platelet aggregation (HP:0003540) | 2.63703260 |
53 | Abnormal platelet function (HP:0011869) | 2.63703260 |
54 | Vacuolated lymphocytes (HP:0001922) | 2.62200111 |
55 | Arterial thrombosis (HP:0004420) | 2.61334348 |
56 | Abnormality of the nasal mucosa (HP:0000433) | 2.61267577 |
57 | Abnormality of T cell physiology (HP:0011840) | 2.57634359 |
58 | Osteomyelitis (HP:0002754) | 2.57373781 |
59 | Retrobulbar optic neuritis (HP:0100654) | 2.54832040 |
60 | Optic neuritis (HP:0100653) | 2.54832040 |
61 | Thrombocytosis (HP:0001894) | 2.54067165 |
62 | Hematochezia (HP:0002573) | 2.50241251 |
63 | Abnormal platelet volume (HP:0011876) | 2.48852869 |
64 | Severe combined immunodeficiency (HP:0004430) | 2.48586058 |
65 | Lymphopenia (HP:0001888) | 2.48200727 |
66 | Chronic diarrhea (HP:0002028) | 2.43935469 |
67 | Viral hepatitis (HP:0006562) | 2.43867440 |
68 | Interstitial pulmonary disease (HP:0006530) | 2.43860881 |
69 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.42477854 |
70 | Combined immunodeficiency (HP:0005387) | 2.41848819 |
71 | Anorexia (HP:0002039) | 2.39172093 |
72 | Petechiae (HP:0000967) | 2.39063133 |
73 | Encephalitis (HP:0002383) | 2.37610212 |
74 | Pulmonary infiltrates (HP:0002113) | 2.36310314 |
75 | * Leukocytosis (HP:0001974) | 2.31843455 |
76 | Increased IgM level (HP:0003496) | 2.31087185 |
77 | Gangrene (HP:0100758) | 2.28836584 |
78 | Slow saccadic eye movements (HP:0000514) | 2.28287191 |
79 | Abnormality of the pleura (HP:0002103) | 2.25270537 |
80 | Hypochromic anemia (HP:0001931) | 2.24913441 |
81 | Dysostosis multiplex (HP:0000943) | 2.24314291 |
82 | Glomerulonephritis (HP:0000099) | 2.23805146 |
83 | Thoracic kyphosis (HP:0002942) | 2.23711607 |
84 | Gastrointestinal stroma tumor (HP:0100723) | 2.23330483 |
85 | Sepsis (HP:0100806) | 2.22421216 |
86 | Hemoptysis (HP:0002105) | 2.20545667 |
87 | IgA deficiency (HP:0002720) | 2.20341697 |
88 | * Granulocytopenia (HP:0001913) | 2.20218205 |
89 | Peritonitis (HP:0002586) | 2.18743536 |
90 | Recurrent sinusitis (HP:0011108) | 2.17972742 |
91 | Chest pain (HP:0100749) | 2.16377080 |
92 | Urticaria (HP:0001025) | 2.16345996 |
93 | IgG deficiency (HP:0004315) | 2.13736702 |
94 | Episodic fever (HP:0001954) | 2.13524689 |
95 | Amaurosis fugax (HP:0100576) | 2.13428886 |
96 | Increased cerebral lipofuscin (HP:0011813) | 2.11299970 |
97 | Hypochromic microcytic anemia (HP:0004840) | 2.09482685 |
98 | * Verrucae (HP:0200043) | 2.08564267 |
99 | * Papilloma (HP:0012740) | 2.08564267 |
100 | Abnormality of the thoracic spine (HP:0100711) | 2.07824946 |
101 | Pulmonary embolism (HP:0002204) | 2.07465337 |
102 | Acute hepatic failure (HP:0006554) | 2.07073691 |
103 | Joint hemorrhage (HP:0005261) | 2.06721297 |
104 | Hypoplasia of the thymus (HP:0000778) | 2.06204714 |
105 | Abnormality of the peritoneum (HP:0002585) | 2.05848301 |
106 | Increased mean platelet volume (HP:0011877) | 2.03796934 |
107 | Microcytic anemia (HP:0001935) | 2.00692069 |
108 | Complement deficiency (HP:0004431) | 2.00483404 |
109 | Menorrhagia (HP:0000132) | 2.00224462 |
110 | Abnormality of the prostate (HP:0008775) | 1.99268033 |
111 | Increased density of long bones (HP:0006392) | 1.98957179 |
112 | Hypergammaglobulinemia (HP:0010702) | 1.98690983 |
113 | Osteolytic defects of the hand bones (HP:0009699) | 1.98622581 |
114 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.98622581 |
115 | Gastrointestinal infarctions (HP:0005244) | 1.97897926 |
116 | Abnormality of the endocardium (HP:0004306) | 1.97804686 |
117 | * Eosinophilia (HP:0001880) | 1.97654277 |
118 | Glomerulopathy (HP:0100820) | 1.97413144 |
119 | Fatigue (HP:0012378) | 1.96350127 |
120 | Papilledema (HP:0001085) | 1.96197600 |
121 | Keratoconjunctivitis sicca (HP:0001097) | 1.96176225 |
122 | Skin rash (HP:0000988) | 1.95498219 |
123 | Mucopolysacchariduria (HP:0008155) | 1.93781794 |
124 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.93781794 |
125 | Vertigo (HP:0002321) | 1.91100296 |
126 | Recurrent pneumonia (HP:0006532) | 1.90147716 |
127 | * Skin ulcer (HP:0200042) | 1.89436170 |
128 | Lymphoma (HP:0002665) | 1.88319521 |
129 | Amyloidosis (HP:0011034) | 1.87210266 |
130 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.85547928 |
131 | * Abnormality of eosinophils (HP:0001879) | 1.85101325 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 4.90174778 |
2 | TYK2 | 2.89327024 |
3 | TXK | 2.75075970 |
4 | MAP3K14 | 2.40691513 |
5 | JAK3 | 2.37958861 |
6 | IRAK4 | 2.35799832 |
7 | PRPF4B | 2.31309648 |
8 | STK10 | 2.31162129 |
9 | TAOK3 | 2.16733446 |
10 | BLK | 2.15693722 |
11 | GRK6 | 2.10746577 |
12 | ZAP70 | 2.10663256 |
13 | KIT | 2.07756513 |
14 | ERN1 | 2.04646303 |
15 | JAK1 | 2.03517128 |
16 | EEF2K | 1.98961308 |
17 | MAP3K10 | 1.98687890 |
18 | CSF1R | 1.97230132 |
19 | BTK | 1.95557011 |
20 | TBK1 | 1.94292858 |
21 | TGFBR2 | 1.87901473 |
22 | ITK | 1.84460680 |
23 | EPHB1 | 1.75607508 |
24 | FGFR4 | 1.75178817 |
25 | IKBKE | 1.72208802 |
26 | SYK | 1.71209822 |
27 | IRAK3 | 1.70930063 |
28 | RIPK4 | 1.67117651 |
29 | CSK | 1.60867418 |
30 | TRIB3 | 1.56796286 |
31 | PKN2 | 1.56524513 |
32 | HCK | 1.55661081 |
33 | MAP3K13 | 1.53879716 |
34 | TEC | 1.52475371 |
35 | CDK12 | 1.46766205 |
36 | IKBKB | 1.44973676 |
37 | FGFR3 | 1.39027561 |
38 | LCK | 1.38559841 |
39 | FES | 1.37649477 |
40 | CAMK1D | 1.37196248 |
41 | BMPR2 | 1.37012136 |
42 | SIK2 | 1.28451768 |
43 | MAP2K3 | 1.28421524 |
44 | LRRK2 | 1.24031723 |
45 | PIM1 | 1.15457041 |
46 | PTK6 | 1.13875837 |
47 | JAK2 | 1.09313470 |
48 | CAMK1G | 1.08316972 |
49 | CLK1 | 1.07534649 |
50 | CHUK | 1.06882984 |
51 | IRAK1 | 1.06513464 |
52 | MAP3K1 | 1.04126315 |
53 | FLT3 | 1.03255518 |
54 | RPS6KA4 | 1.01565476 |
55 | YES1 | 1.01295817 |
56 | LYN | 0.99928341 |
57 | CAMKK2 | 0.94339676 |
58 | TTN | 0.91849205 |
59 | MARK2 | 0.91279639 |
60 | MARK3 | 0.90697460 |
61 | CDK6 | 0.87205899 |
62 | TAOK1 | 0.86701691 |
63 | KSR2 | 0.85987662 |
64 | TRPM7 | 0.85524056 |
65 | NEK9 | 0.84542336 |
66 | CDK4 | 0.79592681 |
67 | MAP3K2 | 0.78109028 |
68 | STK4 | 0.77622055 |
69 | MAP3K11 | 0.77345254 |
70 | SIK1 | 0.76235189 |
71 | PRKCQ | 0.73745629 |
72 | SGK2 | 0.71111220 |
73 | IRAK2 | 0.69567533 |
74 | NLK | 0.68738156 |
75 | WNK1 | 0.67459246 |
76 | PTK2B | 0.63820297 |
77 | MAP3K6 | 0.60484297 |
78 | CAMKK1 | 0.60238992 |
79 | MAP3K7 | 0.59613753 |
80 | EPHA3 | 0.59509340 |
81 | CDK9 | 0.58730977 |
82 | CDC42BPA | 0.58603239 |
83 | NEK2 | 0.58262714 |
84 | PDPK1 | 0.54550652 |
85 | MAPK11 | 0.52098664 |
86 | HIPK2 | 0.52067203 |
87 | MATK | 0.51713924 |
88 | MAPK4 | 0.51385266 |
89 | TNK2 | 0.51049084 |
90 | PRKCH | 0.49556708 |
91 | STK11 | 0.49474489 |
92 | PDK1 | 0.49244693 |
93 | SGK3 | 0.48621842 |
94 | RET | 0.47591588 |
95 | MAP3K8 | 0.47551407 |
96 | FRK | 0.47405188 |
97 | EGFR | 0.46830329 |
98 | MAP3K5 | 0.45537997 |
99 | BRD4 | 0.44701178 |
100 | RAF1 | 0.44282825 |
101 | GRK7 | 0.43722866 |
102 | PRKAA2 | 0.43647815 |
103 | MAPKAPK2 | 0.43482125 |
104 | RPS6KA6 | 0.43324806 |
105 | KDR | 0.43312344 |
106 | ABL1 | 0.41716742 |
107 | PAK4 | 0.39705860 |
108 | CDK19 | 0.39197926 |
109 | STK24 | 0.38946838 |
110 | ALK | 0.37745732 |
111 | MAPK12 | 0.37627158 |
112 | CAMK4 | 0.36359546 |
113 | PRKD2 | 0.36318642 |
114 | STK3 | 0.34923951 |
115 | SMG1 | 0.34399419 |
116 | PDGFRB | 0.34127925 |
117 | MELK | 0.33585441 |
118 | RIPK1 | 0.33471556 |
119 | MAP3K3 | 0.33027639 |
120 | TAOK2 | 0.33018402 |
121 | RPS6KC1 | 0.32608433 |
122 | RPS6KL1 | 0.32608433 |
123 | FGR | 0.31840982 |
124 | SIK3 | 0.29875565 |
125 | MAPK7 | 0.29545338 |
126 | FYN | 0.28094504 |
127 | PIK3CG | 0.28038731 |
128 | TESK2 | 0.27234081 |
129 | MST4 | 0.26555112 |
130 | MAPK3 | 0.26002664 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.37193026 |
2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.88319709 |
3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.84611253 |
4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.80050442 |
5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.66451863 |
6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.64877986 |
7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.32213824 |
8 | Measles_Homo sapiens_hsa05162 | 2.24320491 |
9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.15342857 |
10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.12235663 |
11 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.05696393 |
12 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.03197533 |
13 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.98695936 |
14 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.92358816 |
15 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.87654514 |
16 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.87150648 |
17 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.69441289 |
18 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.66690844 |
19 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.61319799 |
20 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.58961196 |
21 | Other glycan degradation_Homo sapiens_hsa00511 | 1.58900087 |
22 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.57461838 |
23 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.53408084 |
24 | Tuberculosis_Homo sapiens_hsa05152 | 1.53210335 |
25 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.48319134 |
26 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.47844542 |
27 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.46547313 |
28 | Pertussis_Homo sapiens_hsa05133 | 1.46206999 |
29 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.45909295 |
30 | Influenza A_Homo sapiens_hsa05164 | 1.43028308 |
31 | Allograft rejection_Homo sapiens_hsa05330 | 1.39525913 |
32 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.38230142 |
33 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.37899056 |
34 | Apoptosis_Homo sapiens_hsa04210 | 1.36430565 |
35 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.36430363 |
36 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.35603469 |
37 | Legionellosis_Homo sapiens_hsa05134 | 1.33821514 |
38 | Hepatitis B_Homo sapiens_hsa05161 | 1.32617773 |
39 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.32045644 |
40 | Malaria_Homo sapiens_hsa05144 | 1.20942675 |
41 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.20049362 |
42 | Shigellosis_Homo sapiens_hsa05131 | 1.18615047 |
43 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.16202928 |
44 | Viral myocarditis_Homo sapiens_hsa05416 | 1.14398040 |
45 | Platelet activation_Homo sapiens_hsa04611 | 1.12109538 |
46 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.01618301 |
47 | Lysine degradation_Homo sapiens_hsa00310 | 1.00453332 |
48 | Lysosome_Homo sapiens_hsa04142 | 1.00414498 |
49 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.98112633 |
50 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.95119973 |
51 | ABC transporters_Homo sapiens_hsa02010 | 0.94134920 |
52 | Hepatitis C_Homo sapiens_hsa05160 | 0.93988865 |
53 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.89701178 |
54 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.89335790 |
55 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.89279024 |
56 | Asthma_Homo sapiens_hsa05310 | 0.89111873 |
57 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.87658978 |
58 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.86187321 |
59 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.82845961 |
60 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.78603009 |
61 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.78402861 |
62 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.77553727 |
63 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.76884679 |
64 | Salmonella infection_Homo sapiens_hsa05132 | 0.76562414 |
65 | Insulin resistance_Homo sapiens_hsa04931 | 0.76529673 |
66 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.75894553 |
67 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.70875280 |
68 | HTLV-I infection_Homo sapiens_hsa05166 | 0.70435635 |
69 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.70298033 |
70 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.67737806 |
71 | Endometrial cancer_Homo sapiens_hsa05213 | 0.64482904 |
72 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.63853029 |
73 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.61875016 |
74 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.61725197 |
75 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.60560242 |
76 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.59692105 |
77 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.59387311 |
78 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.58088034 |
79 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.57254704 |
80 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.55524161 |
81 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.54960807 |
82 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.54850388 |
83 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.51765343 |
84 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.51504906 |
85 | Colorectal cancer_Homo sapiens_hsa05210 | 0.50875637 |
86 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.50720852 |
87 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.50154306 |
88 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.49363840 |
89 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.46906647 |
90 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.46054706 |
91 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.44685722 |
92 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.44137109 |
93 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.43821024 |
94 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.42687296 |
95 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.42379088 |
96 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.41251462 |
97 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.40739694 |
98 | Glioma_Homo sapiens_hsa05214 | 0.40234154 |
99 | Phagosome_Homo sapiens_hsa04145 | 0.39902557 |
100 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.39520156 |
101 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.39465357 |
102 | Endocytosis_Homo sapiens_hsa04144 | 0.37396698 |
103 | Amoebiasis_Homo sapiens_hsa05146 | 0.37099927 |
104 | Prostate cancer_Homo sapiens_hsa05215 | 0.36350672 |
105 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.35489172 |
106 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.35280768 |
107 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.34772713 |
108 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.34767521 |
109 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.34187717 |
110 | Long-term potentiation_Homo sapiens_hsa04720 | 0.34052870 |
111 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.33069693 |
112 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.31205603 |
113 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.30616743 |
114 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.29984558 |
115 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.29153450 |
116 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.29077292 |
117 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.26792081 |
118 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.26155139 |
119 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.25271566 |
120 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.25253431 |
121 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.25252670 |
122 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.24985974 |